Home » Topics » BioWorld Science

BioWorld Science
RSS

Novo Nordisk discovers GIP-R/GLP-1 receptor coagonists

Feb. 17, 2022

Enanta Pharmaceuticals describes SARS-CoV-2 3C-like proteinase inhibitors

Feb. 17, 2022

Pyruvate kinase isozyme M2 activators identified at the University of Michigan

Feb. 17, 2022

MAL protein seen to regulate epithelial-mesenchymal transition in gastric cancer

Feb. 17, 2022

Financing at Third Harmonic Bio to support development of oral KIT inhibitor THB-001

Feb. 16, 2022

YTHDF1 is involved in renal fibrosis through upregulation of YAP

Feb. 16, 2022

Memo Therapeutics to advance lead programs

Feb. 16, 2022

NIBIOHN and Shionogi announce discovery of novel antiviral antibody for SARS-CoV-2

Feb. 16, 2022

Persistent Ebolavirus in brain seeds relapses

Feb. 16, 2022

NTS-104 reduces critical neuroinflammatory signaling in rat embolic stroke model

Feb. 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...